Ocugen, Inc. (OCGN)
1.39
-0.07
(-4.79%)
USD |
NASDAQ |
May 15, 16:00
1.40
+0.01
(+0.72%)
After-Hours: 20:00
Ocugen Total Assets (Quarterly) : 56.90M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| REGENXBIO, Inc. | 341.89M |
| Catalyst Pharmaceuticals, Inc. | 1.148B |
| Sarepta Therapeutics, Inc. | 3.179B |
| Krystal Biotech, Inc. | 1.397B |
| Gilead Sciences, Inc. | 56.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 51.10M |
| Shareholders Equity (Quarterly) | 5.805M |
| Debt to Equity Ratio | 5.736 |
| Current Ratio | 1.862 |
| Net Debt Paydown Yield | -0.03% |